Search
Browse
Statistics
Feeds

Constitutive DUSP2 expression enhances lymphoid cell proliferation by activating CDK1 and promotes lymphomagenesis

[thumbnail of Original Article]
Preview
PDF (Original Article) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
9MB
[thumbnail of Supplemental Information] Other (Supplemental Information)
5MB

Item Type:Article
Title:Constitutive DUSP2 expression enhances lymphoid cell proliferation by activating CDK1 and promotes lymphomagenesis
Creators: Qian, Yu, Panaampon, Jutatip, Chapuy, Bjoern, Zhang, Xueyan, Zhao, Xiujuan, Wang, Zhe, Zhang, Pengfei, Payungwong, Tongchai, Zhang, Aretina, Ke, Qiang, Zhong, Jing, Yuan, Ping, Zhang, Lei, Hong, Min, Choi, Il-Kyu, Guan, Jiankun, Calado, Dinis Pedro ORCID logoORCID: https://orcid.org/0000-0001-8239-7184, Rodig, Scott, Pozdnyakova, Olga, Rajewsky, Klaus ORCID logoORCID: https://orcid.org/0000-0002-6633-6370, Godinho, Susana A., Jirawatnotai, Siwanon, Wu, Hao, Shipp, Margaret A., Dougan, Stephanie K. and Zhang, Baochun
Abstract:DUSP2 is known as a nuclear dual-specificity phosphatase, highly restricted to immune cells. Its expression is induced by antigenic and mitogenic stimuli and has been implicated in immune cell differentiation and functions. However, its role in immune cell mitotic proliferation and hematologic malignancies has not been rigorously examined. Here, we show DUSP2 is highly expressed in human B-cell, T cell, and other hematologic malignancies. Ablating DUSP2 expression in lymphoma cell lines decreases growth and viability. In mice, transgenic Dusp2 expression promotes B-cell and T cell proliferation, and malignant transformation. Mechanistically, DUSP2 promotes cell cycle progression by activating CDK1 through dephosphorylation at inhibitory Tyr15 and Thr14, which is mediated not by its own phosphatase activity, but instead by a structural motif that recruits CDC25 phosphatases. This work reveals an unexpected oncogenic role for DUSP2 in lymphoid malignancies and the function of a structural motif, which represents an appealing target site for therapeutic intervention.
Source:Cell Reports
ISSN:2211-1247
Publisher:Cell Press / Elsevier
Volume:45
Number:7
Page Range:117652
Date:28 July 2026
Official Publication:https://doi.org/10.1016/j.celrep.2026.117652
PubMed:View item in PubMed
Related to:

Repository Staff Only: item control page

Downloads

Downloads per month over past year

Open Access
MDC Library